Brief: Oncopeptides Posts Q4 Net Loss of SEK 91.1 Million
16/02/2023 07:16
Feb 16 (Reuters) - Oncopeptides Q4 adjusted EPS SEK -1.01. * Q4 EBIT SEK -100.547 million * Q4 net income SEK -91.098 million * Q4 revenue SEK 560 thousand
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy